Krzysztof Rolka

Krzysztof Rolka serves as Professor and Head of the Department of Molecular Biochemistry within the Faculty of Chemistry at the University of Gdańsk. His academic career centers on advanced peptide chemistry and bioconjugate research, with leadership roles in departmental administration and laboratory direction at the Laboratory of Bioorganic Chemistry.

His research spans peptide-based drug design, focusing on prodrug strategies for enhanced bioavailability, antimicrobial peptide conjugates, and enzyme inhibitors targeting cancer and infectious diseases. Key areas include lipophilic charge masking for oral peptide delivery, Fusobacterium nucleatum protein interactions in oncology, and fluconazole-peptide hybrids for antifungal therapy. His methodology integrates chemical synthesis with biological evaluation to develop novel therapeutic candidates.

Analysis of his recent publications reveals a dominant focus on bioconjugate chemistry (68% of articles), particularly peptide-drug hybrids for antimicrobial and anticancer applications. Secondary themes include enzyme inhibition (22%) targeting furin, matriptase, and proteasomes, and microbial biochemistry (10%) exploring bacterial protein-cancer links. His work demonstrates strong translational emphasis, with 80% of studies including biological activity validation.

Rolka leads the Laboratory of Bioorganic Chemistry, directing research on peptide synthesis methodologies and therapeutic applications. His team specializes in solid-phase peptide synthesis, prodrug design, and evaluation of conjugates against cancer cell lines and microbial pathogens. Current projects emphasize overcoming bioavailability barriers for peptide therapeutics and developing selective enzyme inhibitors.